Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.

74 total trials for this combination

Showing top 10 of 74 trials

Trials

NCT ID	Title	Status	Phase
NCT01636817	A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics	TERMINATED	PHASE2
NCT00124982	Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy	COMPLETED	PHASE3
NCT03915964	A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis	COMPLETED	PHASE4
NCT00476996	A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)	TERMINATED	PHASE3
NCT00891020	A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)	COMPLETED	PHASE3
NCT00106574	A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis	COMPLETED	PHASE3
NCT00717236	Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis	COMPLETED	PHASE3
NCT00106522	A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy	COMPLETED	PHASE3
NCT00720798	An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies	COMPLETED	PHASE3
NCT03025308	Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis	COMPLETED	PHASE3

Related Pages

All Rheumatoid arthritis trials All trials in Springfield, United States